๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical predictors of response in metastatic germ cell tumors

โœ Scribed by Grant Taylor; David J. Perry; Robert D. Knight; Nancy A. Dawson; Steven J. Skoog; David G. McLeod


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
556 KB
Volume
62
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Multidisciplinary treatment of metastati
โœ Pritchard, Jon ;Pinkerton, C. Ross ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 136 KB

As Professor D'Angio points out in his introduction, Dr. Willoughby and his colleagues are to be congratulated on the successful outcome of this young girl's management [ 11. However, we would be grateful to have their comments on the following queries: 1. Why was attempted "tissue diagnosis," whic

Two-drug therapy in patients with metast
โœ Dean F. Bajorin; Nancy L. Geller; Steven F. Weisen; George J. Bosl ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 475 KB ๐Ÿ‘ 2 views

Eighty-two patients with metastatic germ cell tumors (GCT) treated with two-drug therapy consisting of etoposide and cisplatin were evaluated for late relapse. Goodrisk GCT was defined using Memorial Sloan-Kettering Cancer Center (MSKCC) criteria. Etoposide was given a t 100 mg/mz on days 1 to 5 and

The role of postchemotherapy surgery in
โœ Stephen D. W. Beck ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 55 KB

Cancer. Patients who present with widely metastatic germ cell tumors (GCTs) are characteristically treated with cisplatin-based chemotherapy. Depending on the patient population selected, approximately 70% of these patients will obtain a complete clinical response, with normalization of serum tumor